Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

C. Michael Gibson, M.D.

Concepts (195)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angioplasty, Balloon, Coronary17201217242.480 Why?
Myocardial Infarction332022114761.710 Why?
Acute Coronary Syndrome15202421941.600 Why?
Platelet Aggregation Inhibitors21202427461.480 Why?
Coronary Circulation12201316111.430 Why?
Thrombolytic Therapy9201120551.190 Why?
Morpholines320145811.020 Why?
Thiophenes320145690.940 Why?
Fibrinolytic Agents10202120750.800 Why?
Electrocardiography12201463870.780 Why?
Purinergic P2Y Receptor Antagonists1020242840.760 Why?
Ticlopidine620177300.750 Why?
Coronary Angiography14202145060.660 Why?
Aspirin10202331290.650 Why?
Electrocardiography, Ambulatory220145770.610 Why?
Stents6202131770.580 Why?
Hemorrhage9202434220.530 Why?
Intercostal Nerves12013280.440 Why?
Coronary Occlusion220143040.440 Why?
Drug Therapy, Combination13202363040.430 Why?
Myocardial Ischemia3201621330.420 Why?
No-Reflow Phenomenon12012160.410 Why?
Denervation120132650.410 Why?
Coronary Artery Disease5202165050.400 Why?
Vitamin K120143130.400 Why?
Adenosine220168050.390 Why?
Immunoglobulin Fab Fragments220114450.370 Why?
Bilirubin120134360.370 Why?
Myocardial Reperfusion220023390.370 Why?
Platelet Glycoprotein GPIIb-IIIa Complex320105780.360 Why?
Anticoagulants5202147950.360 Why?
Drug-Eluting Stents120176810.360 Why?
Atrial Fibrillation3202151140.350 Why?
Polymers1201716170.330 Why?
Enoxaparin220083910.320 Why?
Cryosurgery120134740.300 Why?
Platelet Count220117820.300 Why?
Coronary Thrombosis120114400.300 Why?
Adenosine Monophosphate220212310.290 Why?
Heptanoic Acids120093440.290 Why?
Pravastatin120093920.290 Why?
Peptides4201043530.270 Why?
Hyperemia120082250.270 Why?
Treatment Outcome252023646810.270 Why?
Cyclooxygenase Inhibitors120083610.270 Why?
Monitoring, Physiologic1201417800.270 Why?
Hospital Mortality6201252950.260 Why?
Thrombectomy120117030.260 Why?
Thrombosis3202129440.250 Why?
Ventricular Fibrillation120085370.240 Why?
Uric Acid120118070.240 Why?
Defibrillators, Implantable1201414920.230 Why?
Arrhythmias, Cardiac1201422470.230 Why?
Lymphocytes1201226030.230 Why?
Vascular Patency220059110.230 Why?
Randomized Controlled Trials as Topic122022102180.220 Why?
Heart Rupture, Post-Infarction12003480.220 Why?
Pyrroles1200911240.220 Why?
Pulsatile Flow120043200.210 Why?
Tissue Plasminogen Activator3200411620.200 Why?
Registries4202182470.200 Why?
Middle Aged3020212208530.200 Why?
Coronary Stenosis220058020.190 Why?
Double-Blind Method82017123410.180 Why?
Heparin1200816320.180 Why?
Emergency Medical Services2201119200.180 Why?
Humans5620247612080.170 Why?
Ischemia1200818890.170 Why?
Creatine Kinase120026840.170 Why?
Male3120213606930.160 Why?
Neutrophils1201237630.160 Why?
Antithrombins320162940.160 Why?
Blood Platelets1201024770.160 Why?
Tachycardia, Ventricular1200813050.160 Why?
Female3120213925440.160 Why?
Anti-Inflammatory Agents, Non-Steroidal1200822700.150 Why?
Aged2220211692880.150 Why?
Tyrosine1200214220.150 Why?
Follow-Up Studies72021391260.140 Why?
Postoperative Hemorrhage120214160.140 Why?
Isoenzymes1200216820.140 Why?
Prospective Studies72016544350.130 Why?
Antibodies, Monoclonal2201191870.130 Why?
Secondary Prevention4201614720.130 Why?
Dose-Response Relationship, Drug32017107560.120 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1200932450.120 Why?
Postoperative Complications22017156370.120 Why?
Coronary Disease2201359210.110 Why?
Prognosis62021296870.100 Why?
Angina, Unstable220088900.100 Why?
Clinical Trials, Phase II as Topic120146280.100 Why?
Turkey120112540.090 Why?
Infusions, Intra-Arterial120112210.090 Why?
Transportation of Patients120111740.090 Why?
Coronary Vessels1200231110.090 Why?
Administration, Oral2201740150.090 Why?
Injections, Intra-Arterial120101810.090 Why?
Lymphocyte Count120127810.090 Why?
C-Reactive Protein2201238210.090 Why?
Hirudins120111790.080 Why?
Risk Assessment42021240210.080 Why?
Multivariate Analysis32012120520.080 Why?
Time and Motion Studies120081430.080 Why?
Time Factors72021399570.080 Why?
Drug Dosage Calculations120081170.080 Why?
Blood Flow Velocity2200213750.080 Why?
Endpoint Determination120115900.070 Why?
Contrast Media1200153110.070 Why?
Injections, Intravenous1201013760.070 Why?
Drug Administration Schedule2200848510.070 Why?
Artificial Intelligence1202125760.070 Why?
Diagnostic Tests, Routine120137880.070 Why?
Survival Rate32017127280.070 Why?
Neuralgia120136120.070 Why?
Statistics, Nonparametric2200228540.070 Why?
Nerve Block120137060.070 Why?
Confidence Intervals1201229280.070 Why?
Embolism120103990.070 Why?
Comorbidity22012105160.060 Why?
Ultrasonography, Interventional1201314960.060 Why?
Survival Analysis32011100880.060 Why?
Incidence42021213650.060 Why?
Regional Blood Flow1200814980.060 Why?
Infusions, Intravenous2201722170.060 Why?
Hospitalization12024107070.060 Why?
Efficiency, Organizational120086950.060 Why?
Cardiovascular Diseases12009155200.060 Why?
Plasminogen Activators120041990.060 Why?
Coronary Artery Bypass2202221930.060 Why?
Magnetic Resonance Imaging, Cine1201110610.060 Why?
Stroke2202297210.050 Why?
Adult720162211190.050 Why?
Guideline Adherence1201322200.050 Why?
Medicare1202167730.050 Why?
Atherectomy12002420.050 Why?
Regression Analysis1201263450.050 Why?
Recurrence2200684570.050 Why?
Cardiology1201316930.050 Why?
Creatine Kinase, MB Form120022020.050 Why?
Pyridines1201328720.050 Why?
Recombinant Proteins1201165040.050 Why?
Collateral Circulation120022930.050 Why?
Adolescent32016882980.050 Why?
Societies, Medical1201339230.050 Why?
Retrospective Studies42014806740.040 Why?
Echocardiography1201350060.040 Why?
Angiography, Digital Subtraction120013350.040 Why?
Exercise Test1200721650.040 Why?
Diagnosis, Differential12014129760.040 Why?
Adrenergic beta-Antagonists1200412410.040 Why?
Patient Selection1201142460.040 Why?
Peptide Fragments1201151030.040 Why?
Disease-Free Survival1200868190.040 Why?
Fishes120216000.040 Why?
Angiotensin-Converting Enzyme Inhibitors1200415040.040 Why?
Models, Cardiovascular120039830.040 Why?
Statistics as Topic1200423590.040 Why?
Pericardium120026740.040 Why?
Kaplan-Meier Estimate1200864860.040 Why?
Young Adult22016592210.030 Why?
Chi-Square Distribution1200234180.030 Why?
Combined Modality Therapy1200885190.030 Why?
History, Ancient120162130.030 Why?
United States42021723390.030 Why?
Practice Guidelines as Topic1201374000.030 Why?
Predictive Value of Tests12012153080.030 Why?
Costs and Cost Analysis1202116640.030 Why?
Risk Factors42013742390.030 Why?
Equipment Design1200335100.030 Why?
Research Design1201161800.030 Why?
Fluorescent Dyes1200219010.030 Why?
Analysis of Variance1200262230.030 Why?
Proportional Hazards Models12008124740.030 Why?
Evidence-Based Medicine2201636910.030 Why?
Diabetes Mellitus1201158420.030 Why?
Heart Rate1200441970.030 Why?
Drug Delivery Systems1200322230.020 Why?
Linear Models1200258690.020 Why?
Severity of Illness Index12008158410.020 Why?
History, 21st Century1201615670.020 Why?
Mortality1202128960.020 Why?
Cohort Studies12012414960.020 Why?
History, 20th Century1201627650.020 Why?
Hospitals1202138810.020 Why?
Stroke Volume1200155210.020 Why?
International Cooperation1201314230.020 Why?
Cause of Death1201736880.020 Why?
Cooperative Behavior1201315060.020 Why?
Terminology as Topic1201315280.020 Why?
Pandemics1202486630.010 Why?
Heart Failure12008117010.010 Why?
Consensus1201331340.010 Why?
Logistic Models12011132490.010 Why?
Aged, 80 and over12021589520.010 Why?
Animals120211680790.010 Why?
Gibson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (195)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.